3-[(1R,2S,4R,6S,9S,10R,13R,14R)-2-hydroxy-6-[(2R,4R,5S,6R)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy-9,13-dimethyl-17-oxo-14-tetracyclo[11.3.1.01,10.04,9]heptadecanyl]-2H-furan-5-one

Details

Top
Internal ID fe6dee50-875e-478e-90fe-7f29b849a75d
Taxonomy Organic oxygen compounds > Organooxygen compounds > Carbohydrates and carbohydrate conjugates > Glycosyl compounds > O-glycosyl compounds
IUPAC Name 3-[(1R,2S,4R,6S,9S,10R,13R,14R)-2-hydroxy-6-[(2R,4R,5S,6R)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy-9,13-dimethyl-17-oxo-14-tetracyclo[11.3.1.01,10.04,9]heptadecanyl]-2H-furan-5-one
SMILES (Canonical) CC1C(C(CC(O1)OC2CCC3(C4CCC5(C(CCC4(C5=O)C(CC3C2)O)C6=CC(=O)OC6)C)C)OC)O
SMILES (Isomeric) C[C@@H]1[C@@H]([C@@H](C[C@@H](O1)O[C@H]2CC[C@@]3([C@H]4CC[C@@]5([C@H](CC[C@]4(C5=O)[C@H](C[C@@H]3C2)O)C6=CC(=O)OC6)C)C)OC)O
InChI InChI=1S/C30H44O8/c1-16-26(33)21(35-4)14-25(37-16)38-19-5-8-28(2)18(12-19)13-23(31)30-10-6-20(17-11-24(32)36-15-17)29(3,27(30)34)9-7-22(28)30/h11,16,18-23,25-26,31,33H,5-10,12-15H2,1-4H3/t16-,18+,19+,20-,21-,22-,23+,25+,26+,28+,29-,30-/m1/s1
InChI Key OOROMEHRXBCUBC-MYDGMHNISA-N
Popularity 0 references in papers

Physical and Chemical Properties

Top
Molecular Formula C30H44O8
Molecular Weight 532.70 g/mol
Exact Mass 532.30361836 g/mol
Topological Polar Surface Area (TPSA) 112.00 Ų
XlogP 2.40
Atomic LogP (AlogP) 3.32
H-Bond Acceptor 8
H-Bond Donor 2
Rotatable Bonds 4

Synonyms

Top
There are no found synonyms.

2D Structure

Top
2D Structure of 3-[(1R,2S,4R,6S,9S,10R,13R,14R)-2-hydroxy-6-[(2R,4R,5S,6R)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy-9,13-dimethyl-17-oxo-14-tetracyclo[11.3.1.01,10.04,9]heptadecanyl]-2H-furan-5-one

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9759 97.59%
Caco-2 - 0.7499 74.99%
Blood Brain Barrier - 0.5500 55.00%
Human oral bioavailability + 0.5429 54.29%
Subcellular localzation Mitochondria 0.8454 84.54%
OATP2B1 inhibitior - 0.7086 70.86%
OATP1B1 inhibitior + 0.9132 91.32%
OATP1B3 inhibitior + 0.9726 97.26%
MATE1 inhibitior - 0.9800 98.00%
OCT2 inhibitior - 0.8364 83.64%
BSEP inhibitior + 0.8841 88.41%
P-glycoprotein inhibitior + 0.6405 64.05%
P-glycoprotein substrate + 0.7186 71.86%
CYP3A4 substrate + 0.6926 69.26%
CYP2C9 substrate - 1.0000 100.00%
CYP2D6 substrate - 0.8924 89.24%
CYP3A4 inhibition - 0.8309 83.09%
CYP2C9 inhibition - 0.9043 90.43%
CYP2C19 inhibition - 0.9471 94.71%
CYP2D6 inhibition - 0.9540 95.40%
CYP1A2 inhibition - 0.9087 90.87%
CYP2C8 inhibition - 0.7694 76.94%
CYP inhibitory promiscuity - 0.9394 93.94%
UGT catelyzed + 0.6000 60.00%
Carcinogenicity (binary) - 0.9900 99.00%
Carcinogenicity (trinary) Non-required 0.4628 46.28%
Eye corrosion - 0.9904 99.04%
Eye irritation - 0.9391 93.91%
Skin irritation + 0.4943 49.43%
Skin corrosion - 0.9372 93.72%
Ames mutagenesis - 0.6554 65.54%
Human Ether-a-go-go-Related Gene inhibition + 0.6414 64.14%
Micronuclear - 0.7400 74.00%
Hepatotoxicity - 0.7875 78.75%
skin sensitisation - 0.9150 91.50%
Respiratory toxicity + 0.6556 65.56%
Reproductive toxicity + 0.9333 93.33%
Mitochondrial toxicity + 0.8125 81.25%
Nephrotoxicity - 0.7128 71.28%
Acute Oral Toxicity (c) I 0.8422 84.22%
Estrogen receptor binding + 0.7365 73.65%
Androgen receptor binding + 0.7450 74.50%
Thyroid receptor binding - 0.5371 53.71%
Glucocorticoid receptor binding + 0.7588 75.88%
Aromatase binding + 0.6767 67.67%
PPAR gamma + 0.5324 53.24%
Honey bee toxicity - 0.6230 62.30%
Biodegradation - 0.8000 80.00%
Crustacea aquatic toxicity + 0.6600 66.00%
Fish aquatic toxicity + 0.9692 96.92%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 96.92% 91.11%
CHEMBL4303 P08238 Heat shock protein HSP 90-beta 95.47% 96.77%
CHEMBL1994 P08235 Mineralocorticoid receptor 94.64% 100.00%
CHEMBL4203 Q9HAZ1 Dual specificity protein kinase CLK4 94.27% 94.45%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 94.06% 96.09%
CHEMBL3137262 O60341 LSD1/CoREST complex 93.77% 97.09%
CHEMBL4040 P28482 MAP kinase ERK2 91.14% 83.82%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 90.25% 95.56%
CHEMBL5608 Q16288 NT-3 growth factor receptor 89.72% 95.89%
CHEMBL2581 P07339 Cathepsin D 89.46% 98.95%
CHEMBL1293249 Q13887 Kruppel-like factor 5 87.38% 86.33%
CHEMBL241 Q14432 Phosphodiesterase 3A 85.14% 92.94%
CHEMBL4478 Q00975 Voltage-gated N-type calcium channel alpha-1B subunit 84.40% 97.14%
CHEMBL4026 P40763 Signal transducer and activator of transcription 3 83.53% 82.69%
CHEMBL1806 P11388 DNA topoisomerase II alpha 83.17% 89.00%
CHEMBL1937 Q92769 Histone deacetylase 2 82.88% 94.75%
CHEMBL1871 P10275 Androgen Receptor 81.82% 96.43%
CHEMBL2635 P51452 Dual specificity protein phosphatase 3 81.77% 94.00%
CHEMBL3038469 P24941 CDK2/Cyclin A 81.69% 91.38%
CHEMBL3038477 P67870 Casein kinase II alpha/beta 81.34% 99.23%

Cross-Links

Top
PubChem 76285478
NPASS NPC15257